Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Retained Earnings (2016 - 2025)

Medifast's Retained Earnings history spans 16 years, with the latest figure at $234000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings fell 99.87% year-over-year to $234000.0; the TTM value through Dec 2025 reached $234000.0, down 99.87%, while the annual FY2025 figure was $234000.0, 99.87% down from the prior year.
  • Retained Earnings reached $234000.0 in Q4 2025 per MED's latest filing, up from $220000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $178.5 million in Q2 2025 to a low of $22000.0 in Q1 2024.
  • Average Retained Earnings over 5 years is $58.4 million, with a median of $253500.0 recorded in 2022.
  • The largest YoY upside for Retained Earnings was 142050.41% in 2024 against a maximum downside of 99.99% in 2024.
  • A 5-year view of Retained Earnings shows it stood at $111000.0 in 2021, then surged by 125892.79% to $139.9 million in 2022, then grew by 24.88% to $174.6 million in 2023, then rose by 1.22% to $176.8 million in 2024, then crashed by 99.87% to $234000.0 in 2025.
  • Per Business Quant, the three most recent readings for MED's Retained Earnings are $234000.0 (Q4 2025), $220000.0 (Q3 2025), and $178.5 million (Q2 2025).